GlassScriptPhysician profile
Stephanie Ford
NPI 1598286734
$1,570.88
in general payments reported to CMS, 2019-2025
17 companies · $47.00 in 2025
The $47.00 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $483 · 2022: $537 · 2023: $486 · 2024: $17.99 · 2025: $47.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $551.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $551.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $829.31 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $293.93 | 2022-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $58.74 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $56.02 | 2023 | Austedo Xr, Ajovy |
| Pfizer INC. | $44.95 | 2021-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $44.77 | 2022-2025 | Caplyta |
| Novo Nordisk INC | $37.63 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $36.39 | 2022-2023 | Rexulti |
| Biohaven Pharmaceuticals, INC. | $34.21 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.70 | 2021-2023 | Trintellix |
| Axsome Therapeutics, INC. | $22.95 | 2023 | Auvelity |
| Novartis Pharmaceuticals Corporation | $17.15 | 2021 | |
| Coloplast Corp | $14.49 | 2021 | |
| Mylan Specialty L.P. | $14.08 | 2022 | |
| Merck Sharp & Dohme LLC | $14.04 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $13.28 | 2023 | Trelegy Ellipta |
| Lilly USA, LLC | $11.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.